Bruker Corp. has announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. The clearance marks progress in Bruker’s efforts to develop MALDI-TOF mass spectrometry into the most advanced platform for clinical microbiology identification.
The European Commission has approved the pending...
The Food and Drug Administration has ordered...
OnTarget Laboratories LLC has teamed with partners...
Researchers have developed a system that concentrates foodborne salmonella and other pathogens faster than conventional methods by using hollow thread-like fibers that filter out the cells. The machine, called a continuous cell concentration device, could make it possible to routinely analyze food or water samples to screen for pathogens within a single work shift at food processing plants.
There is certainly no shortage of lab-on-a-chip devices, but in most cases manufacturers have not yet found a cost-effective way to mass produce them. Scientists are now developing a platform for series production of these pocket laboratories. The first major step is moving away from the usual injection molding or wet chemical processing techniques in favor of roll-to-roll processing.
Accelrys Inc. has announced the release of Accelrys Insight and Accelrys Insight for Excel, completing the roll-out of Accelrys’ next-generation cheminformatics suite and providing an interactive, collaborative environment for rapid and effective decision-making in drug discovery.
With the rise of the iPhone, Android and other mobile devices has come a flood of applications designed to help people stay healthy. Food and Drug Administration officials say they will now begin regulating applications and gadgets that work with smartphones to take medical readings and help users monitor their health.
Cancer cells metastasize in several stages—first by invading surrounding tissue, then by infiltrating and spreading via the circulatory system. Some circulating cells work their way out of the vascular network, eventually forming a secondary tumor. Now researchers have developed a microfluidic device that mimics the flow of cancer cells through a system of blood vessels. High-resolution time-lapse imaging captures the moment of metastasis.
According to a recent study published by the National Science Foundation (NSF), businesses spent more on research and development (R&D) in 2011 than they did in 2010. The figures revealed that during 2011, companies in manufacturing industries performed $201 billion, or 68%, of domestic R&D.
A team of researchers at NIST and Applied Research Associates, Inc. has demonstrated an improved microfluidic technique for recovering DNA from real-world, complex mixtures such as dirt. According to the researchers their technique delivers DNA from these crude samples with much less effort and in less time than conventional techniques and yields DNA concentrations optimal for human identification procedures.
MicroRNAs are abundant, small regulatory RNA molecules with diverse cellular functions. But their use as reliable blood-based biomarkers has been undermined by factors such as high interday variability. A new study, however, now shows that droplet digital polymerase chain reaction (ddPCR) technology can be used to precisely and reproducibly quantify microRNA in plasma and serum across different days.
The Department of Systems Biology at the Technical University of Denmark (DTU) have formed a collaboration with Thermo Fisher Scientific to pursue breakthroughs in the understanding of how cellular protein networks drive important diseases. Under the collaboration, Thermo Fisher will provide early access to new technology and designs, and DTU proteomics scientists will provide feedback and collaborate on new applications.
Getting biomolecules past the body’s numerous defenses requires innovations such as drug-delivering nanoparticles. Polylactic acid (PLA) is a potential candidate because it is non-toxic, biodegradable, and spontaneously assembles into tiny structures under the right conditions. Researchers in Singapore have developed a robust method to synthesize PLA nanoparticles using copolymer technology and a rigid “nanocage” made from silicon.
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of Univ. of California, Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin, the fatty, insulating sheath essential to normal neural conduction.
Standard drug-testing methods have shortcomings. Animal testing is expensive and unreliable, and the static environment of cells and cultures don’t mimic the behavior of the entire organism. An interdisciplinary research team at Lehigh Univ. is using microscopy and optical tweezers to develop a new finger-sized chip that can study the activities of cells at the nanoscale, possibly offering an alternative to traditional drug testing.
Since the first test-tube baby was born more than three decades ago, in vitro fertilization has evolved into a highly sophisticated lab procedure. Now, scientists are going back to basics and testing a simpler method that could cost as little as $265 and use basic laboratory equipment that could fit inside a shoebox.
Tissues designed with pre-formed vascular networks are known to promote rapid vascular integration with the host. Generally, prevascularization has been achieved by seeding or encapsulating endothelial cells, but these methods are slow. Hydrogels have also been tried, but a new technique developed in Singapore uses hydrogels with a new patterning process to quickly incorporate different cell types separately into different fibers.
The Wyss Institute for Biologically Inspired Engineering at Harvard Univ. has received a $5.6 million grant award from the U.S. Food and Drug Administration to use its Organs-on-Chips technology to test human physiological responses to radiation. The project will investigate if the microfluidic devices lined by living human cells can be used instead of animals to evaluate the efficacy and safety of medical treatments for radiation sickness.
A recent invention at Purdue Univ. could improve therapy selection for personalized cancer care. Researchers have created a technique called BioDynamic Imaging that measures the activity inside cancer biopsies, or samples of cells. It allows technicians to assess the efficacy of drug combinations, called regimens, on personal cancers.
A team of chemists at Syracuse Univ. has used a temperature-sensitive polymer to regulate DNA interactions in both a DNA-mediated assembly system and a DNA-encoded drug-delivery system. Their findings may improve how nanomaterials self-assemble into functional devices and how anticancer drugs, including doxorubicin, are delivered into the body.
Researchers have shown that test strips bearing gold nanoparticles as sensor elements can detect numerous proteins simultaneously. This new cost-effective method for parallel protein analysis, developed at Johannes Gutenberg Univ. in Mainz, Germany, is, in principle, capable of identifying hundreds of even thousands of different proteins. It could even be used to detect the presence of viruses and their type.
Oxford Gene Technology (OGT), a provider of genetics research and biomarker solutions to advance molecular medicine, has produced a new white paper that is designed to help researchers looking to develop next-generation sequencing strategies. It covers resequencing, methods suitability, data analysis and time and cost considerations.
This week Illumina, Inc. announced the availability of its Phasing Analysis Service. The new sample-to-answer service delivers human whole-genome phase information, empowering gene mapping studies with a more comprehensive view of genomic variation. With phase data, researchers can better understand the effect of genotype on phenotype and variant interaction within a gene.
Biotechnology company Zero Gravity Solutiuons aims to utilize the unique effects of extended zero/micro gravity environments available on the International Space Station to promote gene expression and accelerate stem cell research. The company has completed filings required prior to trading of the company’s stock.
On Thursday, Sigma-Aldrich Corp.announced a partnership with The Scripps Research Institute (TSRI) to fund research and provide immediate, day-of-publication access to TSRI researchers’ discoveries for the synthesis and analysis of potential drugs. The partnership promises to eliminate months from the translation of cutting-edge chemistry into widespread applications for drug discovery.
Scientists at the University of Texas at San Antonio and the U.S. Army Institute of Surgical Research have developed a microarray platform for culturing fungal biofilms that holds 1,200 individual cultures of fungi or bacteria. The nano-scale platform technology could one day be used for rapid drug discovery for treatment of any number of fungal or bacterial infections, or even as a rapid clinical test to identify antibiotic drugs.
Agilent Technologies Inc. this week announced that the Broad Institute in Cambridge, Mass., has become an early adopter of its new Encore Multispan liquid-handling system. The system unites advanced liquid handling and robotic integration for true sample-to-analysis automation.
Duke University biomedical engineers have grown three-dimensional human heart muscle that acts just like natural tissue. The "heart patch" grown in the laboratory from human cells overcomes two major obstacles facing cell-based therapies—the patch conducts electricity at about the same speed as natural heart cells and it "squeezes" appropriately.
- Page 1